Literature DB >> 10906799

The hypocretin/orexin ligand-receptor system: implications for sleep and sleep disorders.

T S Kilduff1, C Peyron.   

Abstract

The molecules originally described as the hypocretins and subsequently as the orexins were initially implicated in the control of food intake. Recent observations implicate this newly-described neurotransmitter system in the sleep disorder narcolepsy and, potentially, in the regulation of normal sleep processes. This article reviews the research that led to the isolation of the hypocretin/orexin peptides, their receptors and the activity of these molecules as we currently understand them. A model is proposed in which the cells that make these peptides might be involved in arousal state control.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10906799     DOI: 10.1016/s0166-2236(00)01594-0

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  86 in total

1.  Release of hypocretin (orexin) during waking and sleep states.

Authors:  Lyudmila I Kiyashchenko; Boris Y Mileykovskiy; Nigel Maidment; Hoa A Lam; Ming-Fung Wu; Joshi John; John Peever; Jerome M Siegel
Journal:  J Neurosci       Date:  2002-07-01       Impact factor: 6.167

Review 2.  Brain mechanisms that control sleep and waking.

Authors:  Jerome Siegel
Journal:  Naturwissenschaften       Date:  2004-07-02

Review 3.  Different neuronal phenotypes in the lateral hypothalamus and their role in sleep and wakefulness.

Authors:  Dmitry Gerashchenko; Priyattam J Shiromani
Journal:  Mol Neurobiol       Date:  2004-02       Impact factor: 5.590

4.  [The neurotransmitter, hypocretin. An overview].

Authors:  C Baumann; C Bassetti
Journal:  Nervenarzt       Date:  2004-04       Impact factor: 1.214

5.  The orexin/hypocretin system in zebrafish is connected to the aminergic and cholinergic systems.

Authors:  Jan Kaslin; Johanna M Nystedt; Maria Ostergård; Nina Peitsaro; Pertti Panula
Journal:  J Neurosci       Date:  2004-03-17       Impact factor: 6.167

Review 6.  Humoral sleep regulation; interleukin-1 and tumor necrosis factor.

Authors:  Kathryn A Jewett; James M Krueger
Journal:  Vitam Horm       Date:  2012       Impact factor: 3.421

7.  Nicotine self-administration in the rat: effects of hypocretin antagonists and changes in hypocretin mRNA.

Authors:  Mark G LeSage; Jennifer L Perry; Catherine M Kotz; David Shelley; William A Corrigall
Journal:  Psychopharmacology (Berl)       Date:  2010-02-24       Impact factor: 4.530

8.  Centrally administered neuropeptide S activates orexin-containing neurons in the hypothalamus and stimulates feeding in rats.

Authors:  Michio Niimi
Journal:  Endocrine       Date:  2006-08       Impact factor: 3.633

9.  GABA-mediated control of hypocretin- but not melanin-concentrating hormone-immunoreactive neurones during sleep in rats.

Authors:  Md Noor Alam; Sunil Kumar; Tariq Bashir; Natalia Suntsova; Melvi M Methippara; Ronald Szymusiak; Dennis McGinty
Journal:  J Physiol       Date:  2004-12-21       Impact factor: 5.182

10.  GABA(B) receptor-mediated modulation of hypocretin/orexin neurones in mouse hypothalamus.

Authors:  Xinmin Xie; Tara L Crowder; Akihiro Yamanaka; Stephen R Morairty; Robin D Lewinter; Takeshi Sakurai; Thomas S Kilduff
Journal:  J Physiol       Date:  2006-04-20       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.